Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Intimation of incorporation of CuraTeQ Biologics (Malta) Limited a new wholly owned stepdown subsidiary.more...
Aurobindo Pharma Limited has informed the Exchange about incorporation of CuraTeQ Biologics (Malta) Limitedmore...
Update on transfer of shares among subsidiary companies.more...
Aurobindo Pharma Limited has updated the Exchange about transfer of shares among subsidiary companiesmore...
Update on acquistion of 26% stake in Swarnaakshu Solar Power Private Limited.more...
Aurobindo Pharma Limited has updated on acquisition of 26% stake in Swarnaakshu Solar Power Private Limitedmore...
Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations...more...
Aurobindo Pharma Ltd has informed that on September 18 2025 at around 8:50 AM a small fire broke out in Granulation Area-10 of Unit IV of AP...more...
Intimation of fire accident at Unit 4 of APL Healthcare Limited a wholly owned subsidiary of the Company.more...
Aurobindo Pharma Limited has informed the Exchange about fire accident at Unit-IV of APL Healthcare Limited a WOS of the Companymore...
Aurobindo Pharma Ltd has announced that its wholly owned subsidiary CuraTeQ Biologics Pvt Ltd has successfully completed a pivotal Phase 3 clinical t...more...
Submission of disclosure of successful of phase 3 clinical study for Denosumab Biosimilar by CuraTeQ Biologics Private Limited a wholly owne...more...
Aurobindo Pharma Limited has informed the Exchange about completion Phase 3 Clinical Study for Denosumab Biosimilar vy CuaTeQ Biologicsmore...
Aurobindo Pharma Limited has informed the Exchange about incorporation of Aurobindo Pharma (Malaysia) SDN. BHD. in Malaysiamore...
Aurobindo Pharma Limited has informed the Exchange about General Updatesmore...
Submission of Clarification Letter on significant movement in Volume of sharesmore...
The Exchange has sought clarification from Aurobindo Pharma Ltd on September 12 2025 with reference to Movement in Volume. The reply is awaited.more...
Submission of Voting Results of 38th AGM along with Scrutinizer Report.more...
Enter Stock
BOARD MEETINGS Company Name : Sacheta Metals L Date : 04-10-2025